By Mill Chart
Last update: Apr 8, 2024
Our stock screener has singled out RESMED INC (NYSE:RMD) as a promising choice for dividend investors. NYSE:RMD not only scores well in profitability, solvency, and liquidity but also offers a decent dividend. We'll explore this further.
ChartMill employs its own Dividend Rating system for all stocks. This score, on a scale of 0 to 10, is determined by evaluating different dividend factors, such as yield, historical performance, dividend growth, and sustainability. NYSE:RMD has been assigned a 7 for dividend:
ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NYSE:RMD, the assigned 7 for health provides valuable insights:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:RMD has earned a 8 out of 10:
Every day, new Best Dividend stocks can be found on ChartMill in our Best Dividend screener.
For an up to date full fundamental analysis you can check the fundamental report of RMD
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
RESMED INC
NYSE:RMD (4/29/2024, 3:15:00 PM)
After market: 217.19 0 (0%)217.19
-0.87 (-0.4%)
What's going on in today's session: S&P500 movers
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Investors liked the healthcare technology company's latest quarterly update.
ResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ResMed (NYSE:RMD) just reported results for the third quarter of 2024.ResMed re...